Financial Performance - The company's operating revenue for the first half of 2022 was CNY 301,387,851.40, representing a 14.71% increase compared to CNY 262,731,048.42 in the same period last year[23]. - Net profit attributable to shareholders increased by 81.95% to CNY 14,975,777.41 from CNY 8,230,726.29 year-on-year[23]. - The net profit after deducting non-recurring gains and losses rose by 89.77% to CNY 13,939,091.25 compared to CNY 7,345,310.55 in the previous year[23]. - Basic earnings per share increased by 82.84% to CNY 0.0245 from CNY 0.0134 in the same period last year[23]. - The total profit for the first half of 2022 was CNY 18,396,274.45, significantly higher than CNY 8,041,870.30 in the same period of 2021, showing an increase of approximately 128.5%[133]. - The total comprehensive income for the first half of 2022 was CNY 14,975,777.41, up from CNY 8,230,726.29 in the first half of 2021, reflecting an increase of approximately 82.5%[134]. - The company reported a net profit of CNY 14,443,506.72 for the first half of 2022, compared to a loss of CNY 532,270.69 in the same period last year[126]. - The company reported a net investment loss of ¥653,158.50, which accounted for -3.55% of total profit[40]. Assets and Liabilities - Total assets at the end of the reporting period reached CNY 1,101,975,349.91, an increase of 11.04% from CNY 992,377,094.35 at the end of the previous year[23]. - The total assets as of June 30, 2022, amounted to CNY 1,101,975,349.91, compared to CNY 992,377,094.35 at the beginning of the year, reflecting a growth of approximately 11%[126]. - Total liabilities increased to CNY 245,152,700.55 from CNY 152,395,723.08, indicating a significant rise in financial obligations[126]. - The total current liabilities increased to CNY 243,761,691.26 from CNY 150,741,415.55, indicating a rise in short-term financial commitments[126]. - The company's equity attributable to shareholders reached CNY 856,822,649.36, up from CNY 839,981,371.27, showing a slight increase in shareholder value[126]. Cash Flow - The company reported a significant decline in net cash flow from operating activities, which was CNY -81,802,866.23, compared to CNY -15,707,317.27 in the same period last year, a decrease of 420.79%[23]. - The net cash flow from operating activities for the first half of 2022 was -81,802,866.23 CNY, compared to -15,707,317.27 CNY in the same period of 2021, indicating a significant decline[139]. - The ending cash and cash equivalents balance for the first half of 2022 was 316,809,873.07 CNY, compared to 298,289,795.30 CNY at the end of the first half of 2021[140]. - The cash and cash equivalents decreased by 28.63% to -CNY 81,340,157.27 compared to -CNY 63,237,348.35 in the previous year[35]. Research and Development - Research and development expenses increased by 96.13% to CNY 15,977,438.59, primarily due to increased direct investment and outsourced R&D costs[34]. - The company has ongoing research and development efforts in new products and technologies, although specific details were not disclosed in the report[38]. - The company has established extensive cooperation with research institutions such as Tsinghua University and the Chinese Academy of Sciences, enhancing its technological innovation capabilities[32]. Market and Revenue Segments - The revenue from environmental water treatment increased by 84.31% to CNY 18,407,750.76, compared to CNY 9,987,140.64 in the previous year[36]. - The company’s revenue from oilfield chemicals was CNY 264,634,321.61, accounting for 87.81% of total revenue, with a year-on-year growth of 58.97%[36]. - Domestic revenue increased by 19.35% to ¥218,444,354, while foreign revenue rose by 20.47% to ¥82,943,497, marking a 109.57% increase in growth rate[38]. Risks and Challenges - The company faces risks related to oil price fluctuations, high customer concentration, and raw material price volatility, which could impact its business performance[4][6]. - The company faces significant risks including oil price fluctuations, high customer concentration, raw material price volatility, exchange rate risks, market expansion challenges, and safety/environmental risks[58]. - The company plans to closely monitor international oil price trends and adjust production plans accordingly to mitigate the impact of price fluctuations[59]. Corporate Governance and Shareholder Relations - The company emphasizes the protection of shareholder interests, particularly for minority shareholders, by ensuring timely and accurate information disclosure[76]. - The company has established a corporate governance structure including a shareholders' meeting, board of directors, and supervisory board[159]. - The total number of ordinary shareholders at the end of the reporting period was 47,108[110]. Environmental Initiatives - The wastewater treatment facility has a processing capacity of 1,500 cubic meters per day and is currently operational, with wastewater being treated and discharged in compliance with standards[70]. - The company has implemented a new rainwater and sewage diversion system to reduce environmental and soil pollution[69]. - The company has developed emergency response plans for potential environmental incidents, which have been filed with the local environmental protection bureau[71]. Investment and Acquisitions - The company agreed to transfer 30% equity of its subsidiary Lida Pharmaceutical to Shanghai XianDao Pharmaceutical for a transaction price of RMB 13 million[100]. - The company signed an investment intention agreement to acquire up to 20% equity in Liling Rijing Mining Development Co., Ltd. and Liling Hongbo Mining Development Co., Ltd.[102]. - The company is actively exploring strategic mergers and acquisitions to bolster its market position and operational capabilities[155]. Financial Reporting and Compliance - The financial report for the first half of 2022 was not audited[122]. - The financial statements comply with the enterprise accounting standards and reflect the company's financial position as of June 30, 2022[167]. - The company has assessed its ability to continue as a going concern for the next 12 months and found no significant doubts regarding its sustainability[165].

山东宝莫生物化工股份有限公司 2022 年第一季度报告全文 证券代码：002476 证券简称：宝莫股份 公告编号：2022-018 山东宝莫生物化工股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中 财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 147,248,909.05 | 103,188,557.65 | 42.70% | | 归属于上市公司股东的净利润（元） | 9,874,608.10 | 203, ...

Financial Performance - The company's operating revenue for 2021 was CNY 657,160,020.80, representing a 46.91% increase compared to CNY 447,314,622.27 in 2020[18]. - The net profit attributable to shareholders for 2021 was CNY 17,948,109.83, up 36.15% from CNY 13,182,608.80 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was CNY 14,998,806.19, a 17.31% increase from CNY 12,785,450.82 in 2020[18]. - The basic earnings per share for 2021 was CNY 0.0293, reflecting a 36.28% increase from CNY 0.0215 in 2020[19]. - The total assets at the end of 2021 were CNY 992,377,094.35, a decrease of 1.75% from CNY 1,010,062,108.61 at the end of 2020[19]. - The net assets attributable to shareholders increased by 2.19% to CNY 839,981,371.27 from CNY 822,017,035.36 in 2020[19]. - The net cash flow from operating activities was negative at CNY -34,809,678.63, a decline of 207.05% compared to CNY 32,516,430.47 in 2020[18]. - The weighted average return on equity for 2021 was 2.16%, up from 1.62% in 2020[19]. Revenue Breakdown - The chemical business generated revenue of 473,776,207.52 yuan, with a cost of 400,336,018.71 yuan, reflecting increases of 18.71% and 18.03% respectively[38]. - The environmental water treatment business reported revenue of 28,462,555.70 yuan, a 204.22% increase, with costs rising by 129.44% to 23,308,614.88 yuan[38]. - Domestic revenue accounted for 84.93% of total revenue, amounting to ¥558,155,667.17, which is a 58.34% increase year-on-year[43]. - The revenue from photovoltaic power generation decreased by 37.74% to ¥23,561,152.51, down from ¥37,842,627.69 in 2020[43]. - The sales volume of photovoltaic power generation decreased by 37.22% to 36,730,000 kWh in 2021 from 58,510,000 kWh in 2020[50]. Market Strategy and Expansion - The company is a leading supplier of polyacrylamide, primarily serving the oil and gas development and wastewater treatment markets[30]. - The company has expanded its market presence in North America, Southeast Asia, Central Asia, and the Middle East through e-commerce and international exhibitions[30]. - The company aims to enhance its overall profitability and sustainable development capabilities by focusing on technological innovation and market expansion[29]. - The company has adjusted its market strategy to stabilize its main business amidst increasing competition in the chemical industry[30]. - The company plans to strengthen market expansion in oilfield products, focusing on surfactants, temperature-resistant and salt-resistant polyacrylamide, and offshore oil extraction agents to improve profitability[89]. Research and Development - The company filed 12 patents and received 4 authorized patents during the year, bringing the total to 28 patents[36]. - The company’s R&D expenses increased by 25% year-on-year, reflecting ongoing investment in innovation[39]. - The company is focusing on the development of a new type of anionic long-fiber papermaking additive to enhance paper quality during production[62]. - The company is conducting industrial trials for a high-efficiency flocculant specifically for aluminum production, which is expected to enhance product quality and market reach[60]. - The company's R&D investment increased by 25.00% to ¥22,397,556.64 in 2021 from ¥17,918,195.32 in 2020[64]. Management and Governance - The company has established a comprehensive governance structure, including various committees to ensure effective decision-making and compliance with regulations[96]. - The company has committed to avoiding any competition with its controlling shareholder, ensuring a clear operational boundary[101]. - The company appointed Zhao Gang as the new General Manager on April 2, 2021, following the resignation of the previous General Manager Wu Feng[107]. - The company has established a performance-based compensation system for its internal directors and senior management[116]. - The board of directors held a total of 22 meetings during the reporting period, with significant resolutions including the approval of the 2021 annual report and the establishment of wholly-owned subsidiaries[119][120]. Environmental and Safety Management - The company has established a wastewater treatment facility with a processing capacity of 1,200 cubic meters per day, ensuring compliance with environmental standards[147]. - The company operates a 40T/H boiler with desulfurization and denitrification equipment, achieving ultra-low emissions[147]. - The company has implemented an emergency response plan for environmental incidents, which has been filed with the local environmental protection bureau[149]. - The company has committed to maintaining zero safety and environmental accidents throughout the year by enhancing safety and environmental management practices[89]. - In 2021, the company allocated 3.7 million yuan for safety production expenses, with actual usage at 3.6843 million yuan, indicating a focus on safety management[153]. Financial Management - The company reported a loss in investment income of -¥2,263,497.03, accounting for -12.79% of total profit[68]. - The company has established an independent financial department with its own accounting system and management practices, ensuring financial independence[101]. - The company has not reported any significant changes in its accounting policies for derivatives compared to the previous reporting period[81]. - The company has not faced any administrative penalties for environmental issues during the reporting period[150]. - The company has not engaged in poverty alleviation or rural revitalization efforts during the reporting period[154].

Financial Performance - The company's operating revenue for 2021 was CNY 657,160,020.80, representing a 46.91% increase compared to CNY 447,314,622.27 in 2020[19] - The net profit attributable to shareholders for 2021 was CNY 17,948,109.83, up 36.15% from CNY 13,182,608.80 in the previous year[19] - The net profit after deducting non-recurring gains and losses was CNY 14,998,806.19, reflecting a 17.31% increase from CNY 12,785,450.82 in 2020[19] - The basic earnings per share for 2021 was CNY 0.0293, a 36.28% increase from CNY 0.0215 in 2020[20] - The total assets at the end of 2021 were CNY 992,377,094.35, a decrease of 1.75% from CNY 1,010,062,108.61 at the end of 2020[20] - The net assets attributable to shareholders increased by 2.19% to CNY 839,981,371.27 at the end of 2021, compared to CNY 822,017,035.36 at the end of 2020[20] - The net cash flow from operating activities was negative CNY 34,809,678.63, a decline of 207.05% from CNY 32,516,430.47 in 2020[19] - The weighted average return on equity for 2021 was 2.16%, up from 1.62% in 2020[20] Revenue Breakdown - The chemical business generated revenue of CNY 473,776,207.52, with a cost of CNY 400,336,018.71, reflecting increases of 18.71% and 18.03% respectively[39] - The water treatment business reported revenue of CNY 28,462,555.70, a 204.22% increase, with costs rising by 129.44% to CNY 23,308,614.88, marking a turnaround to profitability[39] - The revenue from the chemical raw materials and chemical products manufacturing industry was ¥473,776,207.52, accounting for 72.09% of total revenue, with a year-on-year growth of 18.71%[44] - The revenue from environmental water treatment surged by 204.22% to ¥28,462,555.70, increasing its share of total revenue to 4.33%[44] Cash Flow and Investments - The net cash flow from operating activities turned negative at approximately CNY -34.81 million, a decrease of 207.05% from a positive CNY 32.52 million in the previous year[67] - Investment activities generated a net cash inflow of approximately CNY 119.47 million, a significant increase of 1,254.86% from CNY 8.82 million in 2020[67] - The company's cash and cash equivalents increased by approximately CNY 36.62 million, a 225.74% improvement from a decrease of CNY -29.13 million in the previous year[67] Research and Development - The company filed 12 patents and received 4 patents in the reporting year, bringing the total to 28 patents[33] - The company's research and development expenses increased by 25.00%, rising from 17,918,195.32 yuan in 2020 to 22,397,556.64 yuan in 2021[60] - The number of R&D personnel remained stable at 69, accounting for 14.08% of the total workforce in 2021, a slight decrease from 14.65% in 2020[65] - Development of a new salt-resistant polymer fracturing fluid system is underway, aimed at expanding the company's product market[61] Market Expansion and Strategy - The company aims to enhance overall profitability and sustainable development by focusing on technological innovation, market expansion, and management improvement[30] - The company has implemented strategies to stabilize its main business while exploring new business opportunities amid a competitive chemical industry[31] - The company plans to enhance its product structure and upgrade product performance to address challenges in overseas markets, including trade sanctions and shipping difficulties[50] - The company plans to enhance market expansion in oilfield products, focusing on surfactants and offshore oilfield additives, while also targeting water treatment and paper-making markets[92] Governance and Management - The company has established a complete independent financial management system, ensuring no financial interference from the controlling shareholder[104] - The company has a fully independent operational structure, with no overlapping personnel with the controlling shareholder[104] - The company has implemented effective internal control measures to enhance management efficiency and risk prevention capabilities[102] - The company has a diverse board composition, with a mix of independent and internal directors, promoting a balanced approach to governance[121] Environmental and Safety Management - The company has established a wastewater treatment facility with a capacity of 1,200 cubic meters per day, which is currently operating normally[150] - The company has implemented ultra-low emission modifications for its 40T/H boiler, which is equipped with desulfurization and denitrification devices[150] - The company has committed to maintaining shareholder interests through regular information disclosure and investor relations activities[154] - The company emphasizes the importance of safety and environmental protection, aiming for zero safety incidents throughout the year[92] Risks and Challenges - The company faces risks related to oil price fluctuations, high customer concentration, and raw material price volatility, which could impact its financial performance[94] - The company has reported various risks faced during operations, which are detailed in the management discussion and analysis section[4] Employee and Compensation - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 919.94 million[120] - The performance-based compensation for internal directors and executives is determined based on operational performance, reflecting the company's commitment to aligning pay with performance[119] - The company has implemented a performance-based compensation system, aligning employee incentives with company performance[136] Shareholder and Board Activities - The company held its annual shareholders' meeting on May 13, 2021, with a participation rate of 16.16%[106] - The board of directors convened nine meetings in 2021, discussing various important matters including the 2020 annual report and the 2021 first-quarter report[101] - The company has experienced changes in its board of directors, with multiple resignations and new appointments in 2021[110] Financial Reporting and Compliance - The company reported zero significant defects in financial reporting and internal controls for the year 2021[146] - The company has a complete governance structure in place, ensuring compliance with laws and regulations, with no serious violations reported[145] - The company has not faced any penalties from securities regulatory agencies in the past three years[118]

证券代码：002476 证券简称：宝莫股份 公告编号：2021-047 山东宝莫生物化工股份有限公司 关于参加山东辖区上市公司 2021 年度投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的沟通交流，构建和谐投资者关系，山东宝莫生物化 工股份有限公司（以下简称"公司"）将参加由山东证监局、山东上市公司协会 与深圳市全景网络有限公司联合举办的"山东辖区上市公司 2021 年度投资者网 上集体接待日活动"，现将有关事项公告如下： 本次集体接待日活动将通过深圳市全景网络有限公司提供的网上平台举行， 广大投资者可登陆"全景·路演天下"网址（http://rs.p5w.net）参与公司互 动交流，互动交流的时间为 2021 年 11 月 16 日 14:00 - 16:00。 届时公司副总经理、董事会秘书张世鹏先生以及证券事务代表王建国先生将 通过网络在线互动的形式，与广大投资者就公司治理及社会责任/ESG、经营状况、 发展战略、风险防控、投资者保护、三季度报告等投资者关心的问题进行交流。 欢迎广大投资者积极参与！ ...

山东宝莫生物化工股份有限公司 2021 年第三季度报告 证券代码：002476 证券简称：宝莫股份 公告编号：2021-040 山东宝莫生物化工股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度 报告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年同期增 | 年初至报告期末 | 年初至报告期末比上年 | | --- | --- | --- | --- | --- | | | | 减 | | 同期增减 | | 营业收入（元） | 218,661,676.08 | 177.39% | 481,392,724.50 | 5 ...

Financial Performance - The company's operating revenue for the first half of 2021 was ¥262,731,048.42, representing a 13.05% increase compared to ¥232,397,594.15 in the same period last year[18]. - The net profit attributable to shareholders decreased by 40.97% to ¥8,230,726.29 from ¥13,944,248.92 year-on-year[18]. - The net profit after deducting non-recurring gains and losses fell by 46.00% to ¥7,345,310.55 compared to ¥13,602,273.99 in the previous year[18]. - Basic earnings per share decreased by 41.23% to ¥0.0134 from ¥0.0228 year-on-year[18]. - The company achieved operating revenue of ¥262,731,048.42, an increase of 13.05% compared to the same period last year[29]. - Net profit attributable to shareholders decreased by 40.97% to ¥8,230,726.29, primarily due to a decline in chemical product sales[29]. - The company reported a total comprehensive income of CNY 8,230,726.29 for the first half of 2021, compared to CNY 13,944,248.92 in the same period of 2020[135]. - The total comprehensive income for the first half of 2021 decreased by CNY 949.32 million compared to the previous period[154]. Cash Flow and Investments - The net cash flow from operating activities was negative at -¥15,707,317.27, a decline of 149.09% from ¥31,999,666.37 in the same period last year[18]. - Cash inflow from operating activities was 291,554,822.30 yuan in the first half of 2021, an increase from 217,048,859.28 in the same period of 2020[141]. - The net cash flow from investing activities was -6,169,643.70 yuan, compared to -763,041.93 yuan in the previous period, reflecting increased investment expenditures[143]. - The company reported a significant increase in cash paid for investments, totaling 100,000,000.00 yuan, compared to 5,000,000.00 yuan in the previous period[146]. Revenue Breakdown - Chemical business revenue was ¥178,225,144.56, down 16.23% year-on-year, with costs at ¥158,032,729.97, a decrease of 10.48%[29]. - Environmental water treatment business generated revenue of ¥9,987,140.64, with costs of ¥10,341,481.01, marking the resumption of operations from a previous project[29]. - The photovoltaic power generation business reported revenue of ¥18,185,046.32, with costs of ¥6,929,721.85, reflecting a decrease of 7.32% in revenue[29]. - The company's domestic revenue reached CNY 223,153,591.54, an increase of 12.58% compared to the previous year[39]. - International revenue amounted to CNY 39,577,456.88, reflecting a growth of 14.60% year-over-year[39]. Assets and Liabilities - Total assets increased by 2.63% to ¥1,036,645,789.26 from ¥1,010,062,108.61 at the end of the previous year[18]. - The company's total assets as of June 30, 2021, amounted to CNY 887,446,834.41, slightly up from CNY 886,492,636.72 at the end of 2020[130]. - The total liabilities increased to CNY 204,864,403.93 in the first half of 2021 from CNY 188,045,073.25 in the previous year, marking an increase of 8.73%[127]. - The company's total investment during the reporting period was CNY 100,000,000, a decrease of 16.88% from CNY 120,308,000 in the same period last year[46]. Operational Developments - The company established a wholly-owned subsidiary, Shanghai Baomo, to explore new business opportunities and enhance competitive strength[27]. - The company has formed extensive partnerships with research institutions like Tsinghua University and the Chinese Academy of Sciences to enhance its technological innovation capabilities[28]. - The company established Shanghai Baomo with a registered capital of CNY 10,000,000, focusing on the sale of chemical raw materials and products[39]. - The company has a total of four production projects related to polyacrylamide, with annual capacities of 10,000 tons and 13,000 tons for different types of polyacrylamide[68]. Risk Factors - The company faces risks related to oil price fluctuations, high customer concentration, raw material price volatility, and exchange rate risks, which could significantly affect its business[56]. - The company is closely monitoring international oil price trends to adjust production plans and manage inventory effectively in response to market fluctuations[57]. Governance and Compliance - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board[161]. - The financial report for the first half of 2021 was not audited, which may affect the reliability of the financial data presented[122]. - The company has complied with environmental monitoring regulations and has commissioned third-party agencies for pollution monitoring[69]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 43,686[110]. - The largest shareholder, Tibet Taiyifengxin Technology Co., Ltd., holds 15.80% of the shares, totaling 96,698,025 shares[110]. - The company has not reported any significant changes in shareholding structure or major shareholder movements during the reporting period[109].

Financial Performance - The company's operating revenue for Q1 2021 was ¥103,188,557.65, representing a decrease of 19.76% compared to ¥128,605,611.93 in the same period last year[7]. - The net profit attributable to shareholders was ¥203,436.18, a significant decline of 96.07% from ¥5,181,202.60 year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥165,410.04, down 103.24% from ¥5,105,536.23 in the previous year[7]. - Basic earnings per share were ¥0.0003, down 96.47% from ¥0.0085 year-on-year[7]. - Net profit decreased by 96.07% compared to the same period last year, mainly due to a decrease in overseas sales of chemical products[15]. - The operating profit decreased to 288,441.38 from 587,136.79 million, representing a decline of approximately 50.9%[39]. - The net profit for the current period is 288,441.38 million, down from 587,136.79 million, indicating a decrease of about 50.9%[40]. Cash Flow - The net cash flow from operating activities was -¥24,432,535.55, a decrease of 166.41% compared to ¥36,788,137.20 in the same period last year[7]. - Cash inflow from operating activities totaled 107,093,739.97, compared to 171,729,893.63 in the previous period, reflecting a decline of approximately 37.6%[42]. - Cash outflow from operating activities was 131,526,275.52, slightly decreased from 134,941,756.43, resulting in a net cash flow from operating activities of -24,432,535.55[43]. - The company reported a decrease in other cash receipts related to operating activities, which fell to 2,546,054.34 from 50,887,612.24[42]. - The company experienced a net cash outflow from financing activities of -5,533,496.05, compared to -27,408,262.09 in the previous period, indicating an improvement in cash flow management[44]. - The net cash flow from investing activities decreased by 491.31% compared to the same period last year, mainly due to an increase in cash paid for asset purchases[15]. - The net cash flow from investment activities was -5,000,000.00 RMB, indicating a cash outflow for investments[47]. - The net increase in cash and cash equivalents for the period was -4,797,921.44 RMB, compared to a decrease of 5,685,068.10 RMB in the previous period[47]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,006,374,482.49, a slight decrease of 0.37% from ¥1,010,062,108.61 at the end of the previous year[7]. - Total liabilities as of March 31, 2021, were CNY 379,882.81, down from CNY 653,165.86 at the end of 2020[31]. - The total current assets amounted to 568,918,435.66 RMB as of January 1, 2021[50]. - The total non-current assets were 441,143,672.95 RMB, remaining unchanged from the previous period[50]. - The company's equity attributable to shareholders was 822,017,035.36 RMB as of January 1, 2021[51]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 45,866[10]. - The largest shareholder, Tibet Taiyifeng Information Technology Co., Ltd., held 15.80% of the shares, amounting to 96,698,030 shares[10]. - The net assets attributable to shareholders at the end of the reporting period were ¥823,007,595.67, an increase of 0.12% from ¥822,017,035.36 at the end of the previous year[7]. Operational Changes - Prepayments increased by 102.81% compared to the beginning of the period, mainly due to an increase in advance payments for materials[14]. - Inventory increased by 37.83% compared to the beginning of the period, primarily due to an increase in chemical inventory despite a decrease in sales volume[14]. - Fixed assets decreased by 30.46% compared to the beginning of the period, mainly due to reclassification of finance lease fixed assets to right-of-use assets under new leasing standards[14]. - Right-of-use assets increased by 100% compared to the beginning of the period, reflecting the reclassification of finance lease fixed assets[14]. - Contract liabilities increased by 465.21% compared to the beginning of the period, primarily due to an increase in advance receipts[14]. - R&D expenses decreased by 30.24% compared to the same period last year, mainly due to a reduction in direct investment[15]. - Financial expenses decreased by 59.28% compared to the same period last year, primarily due to a decrease in bank loan interest[15]. - The company has implemented new leasing standards affecting the classification of fixed assets and liabilities[52]. Other Income - The company reported non-recurring gains and losses totaling ¥368,846.22 during the reporting period[8]. - Other income for Q1 2021 was CNY 366,874.92, an increase from CNY 86,150.54 in the previous period[34].

Financial Performance - The company's operating revenue for 2020 was ¥447,314,622.27, representing a 7.30% increase compared to ¥416,892,274.68 in 2019[24]. - The net profit attributable to shareholders of the listed company decreased by 85.55% to ¥13,182,608.80 from ¥91,245,926.27 in 2019[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥12,785,450.82, a significant increase of 142.98% compared to a loss of ¥29,747,189.13 in 2019[24]. - Basic and diluted earnings per share dropped by 85.58% to ¥0.0215 from ¥0.1491 in the previous year[26]. - The weighted average return on net assets fell to 1.62%, down 10.34% from 11.96% in the previous year[26]. - The net cash flow from operating activities decreased by 35.69% to ¥32,516,430.47 compared to ¥50,563,549.67 in the previous year[26]. - The company reported a significant increase in accounts receivable, which rose by 80.37% compared to the beginning of the year, primarily due to increased overseas sales of chemical products[37]. - The company achieved a total revenue of 45,547,499.1 yuan from non-oilfield chemicals, reflecting a decrease of 3.96% due to fluctuations in raw material prices[59]. - The company reported a net profit attributable to shareholders of 13.18 million yuan for 2020, a decrease from 91.25 million yuan in 2019 and a loss of 26.41 million yuan in 2018[102]. Dividend Policy - The company plans not to distribute cash dividends or issue bonus shares for the year[13]. - The company did not distribute any cash dividends in 2020, 2019, or 2018, maintaining a policy of no profit distribution due to negative retained earnings in the consolidated financial statements[102]. Risks and Challenges - The company faces risks related to high customer concentration, primarily relying on major clients like Sinopec and PetroChina[7]. - Fluctuations in raw material prices, particularly acrylonitrile, directly impact production costs and profitability[8]. - The company is exposed to risks from oil price volatility, which can significantly affect business development and operating performance[6]. - The company has identified market expansion risks due to increasing competition and potential ineffective marketing strategies[10]. - The company’s overseas business is subject to exchange rate risks due to transactions being denominated in USD[11]. - The company faces risks related to oil price fluctuations, high customer concentration, raw material price volatility, market expansion challenges, exchange rate fluctuations, and potential force majeure events[101]. Operational Efficiency and Market Strategy - The company plans to strengthen market development and maintain existing product market share in response to the ongoing challenges posed by the COVID-19 pandemic[36]. - The company aims to enhance its core capabilities through technological innovation and improve profitability amidst a challenging economic environment[36]. - The company has actively adjusted its product structure and marketing strategies in response to market demand, leading to improved operational efficiency[45]. - The company has implemented multiple technical improvements, including upgrades to granulation and screening systems, which have further optimized production efficiency and reduced costs[44]. - The company has successfully developed several new products, including high salt-resistant polyacrylamide and high-efficiency cationic polymers, enhancing its product portfolio[45]. Research and Development - The company has developed a total of 24 proprietary technologies and holds 24 patents, positioning its core technology as a leader in the industry[40]. - Research and development expenses for the year were ¥17,918,195.32, which is 4.01% of total revenue, with a decrease of 8.79% compared to the previous year[74]. - The company has invested 200 million RMB in R&D for new technologies aimed at improving production efficiency by 30%[180]. Environmental and Safety Management - The company is classified as a key pollutant discharge unit, with wastewater treatment capacity of 1,500 cubic meters per day and has implemented ultra-low emission modifications for its boiler[143][145]. - The company has established emergency response plans for potential environmental incidents and has filed necessary documents with local environmental authorities[146]. - The company has implemented safety management systems and has not experienced any major safety incidents in 2020, with a safety management budget of 3.65 million CNY and actual expenditure of 4.36 million CNY[141]. Shareholder and Governance - The company emphasizes shareholder interests, particularly for minority shareholders, and maintains good communication through various platforms[140]. - Independent directors actively participate in decision-making, ensuring fairness and protecting the rights of minority shareholders[193]. - The company has maintained a consistent relationship with its accounting firm, which has provided audit services for 16 consecutive years[117]. - The company strictly adheres to legal regulations in its governance practices, ensuring the legitimacy of shareholder meetings and board decisions[193]. Future Outlook - The company provided a future outlook with a revenue guidance of 1.8 billion RMB for the next fiscal year, indicating a growth target of 20%[180]. - The company is expanding its market presence in Southeast Asia, targeting a 15% market share by the end of 2022[180]. - The company anticipates continued growth in oil demand as the global pandemic stabilizes, despite facing significant operational pressures[96].

Financial Performance - Operating revenue for the reporting period was ¥78,829,531.58, a decrease of 14.62% year-on-year, while year-to-date revenue was ¥311,227,125.73, down 8.18% compared to the same period last year[7] - Net profit attributable to shareholders was -¥579,833.53, representing an increase of 83.94% year-on-year, while year-to-date net profit was ¥13,364,415.39, a significant increase of 2,054.94%[7] - Basic and diluted earnings per share were both -¥0.0009, reflecting an increase of 84.75% year-on-year, while year-to-date earnings per share were ¥0.0218, up 2,080.00%[7] - Total operating revenue for the period was CNY 311,227,125.73, a decrease of 8.2% compared to CNY 338,947,778.19 in the previous period[46] - Net profit for the period was CNY -579,833.53, an improvement from CNY -3,610,687.22 in the same period last year[40] - Basic and diluted earnings per share were both CNY -0.0009, compared to CNY -0.0059 in the previous year[41] Cash Flow - The net cash flow from operating activities was -¥5,379,482.78, a decline of 121.43% compared to the same period last year, while year-to-date cash flow was ¥26,620,183.59, up 1.98%[7] - Net cash flow from operating activities was 26.62 million yuan, an increase of 1.98% year-on-year, mainly due to the release of a performance guarantee deposit related to oil and gas exploration rights[17] - The company reported a net cash flow from operating activities of CNY 26,620,183.59 for Q3 2020, slightly up from CNY 26,102,865.20 in Q3 2019[55] - The net cash flow from operating activities was -36,376,612.04 yuan, a significant decrease compared to 5,106,123.56 yuan in the previous period[57] - The company reported a net cash outflow from investment activities of -7,112,301.65 yuan, compared to a net inflow of 56,079,032.52 yuan in the previous period[56] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,007,978,957, an increase of 4.42% compared to the end of the previous year[7] - The total liabilities amounted to CNY 184,302,848.32, compared to CNY 156,452,515.78 in the previous period[32] - Current liabilities totaled CNY 92,503,431.47, down from CNY 146,491,809.49 in the previous period[32] - The total equity attributable to shareholders was CNY 823,676,108.68, an increase from CNY 808,834,426.56[33] - The company’s total liabilities and equity combined reached CNY 897,744,826.22, reflecting a stable financial position[69] Shareholder Information - The total number of shareholders at the end of the reporting period was 50,137, with the top ten shareholders holding a combined 27.96% of the shares[11] - The largest shareholder, Tibet Taiyifeng Information Technology Co., Ltd., held 15.80% of the shares, amounting to 96,698,030 shares[11] - The company did not engage in any repurchase transactions among the top ten shareholders during the reporting period[12] Operational Insights - Operating revenue and operating costs decreased by 8.18% and 15.29% year-on-year, respectively, primarily due to reduced customer orders in the chemical business impacted by the pandemic[16] - Financial expenses increased by 198.53% year-on-year, mainly due to the consolidation of Nengjing Photovoltaic[16] - Research and development expenses were CNY 3,613,202.30, slightly up from CNY 3,568,035.85 year-over-year[39] - Sales expenses increased to CNY 5,214,288.15 from CNY 3,395,215.29, reflecting a rise of 53.6%[39] - Management expenses decreased to CNY 5,153,480.48 from CNY 8,370,844.56, a reduction of 38.5%[39] Tax and Other Financial Metrics - The company reported a 97.18% decrease in income tax expenses year-on-year, mainly due to the reversal of temporary differences related to loss compensation[16] - Tax and additional charges were CNY 662,662.10, down from CNY 1,140,761.17, indicating a decrease of 41.8%[39] Investment and Equity - The company reported non-operating income of ¥490,166.17 for the year-to-date period, primarily from government subsidies and asset disposals[8] - Long-term receivables amounted to CNY 7,125,050.00, while long-term equity investments were CNY 14,414,752.92[31] - The company’s long-term equity investments were valued at CNY 391,336,789.98, contributing significantly to its non-current asset portfolio[67]